Corticosteroid rescue in late paediatric acute respiratory distress syndrome

Area of Science:

• Pediatric Critical Care Medicine
• Pulmonology
• Pharmacology

Background:

• Late acute respiratory distress syndrome (ARDS) carries a high mortality rate, exceeding 80%.
• Adult studies suggest prolonged steroid therapy improves survival in late ARDS, but pediatric data are limited.
• Refractory late ARDS in children presents a significant clinical challenge with few effective treatment options.

Observation:

• A case report details the successful treatment of a child with refractory late ARDS.
• The child had been on advanced mechanical ventilation for 12 days prior to treatment.
• High-dose methylprednisolone was administered for a prolonged duration.

Findings:

• Significant clinical improvement was observed within 14 days of steroid initiation.
• Improvements noted in oxygenation (PaO2/FiO2 ratios), lung injury scores, and chest radiography.
• A fungal urinary tract infection was managed successfully; no major metabolic side effects occurred.

Implications:

• Prolonged steroid therapy may be a viable option for refractory pediatric late ARDS.
• Further prospective studies are essential to establish optimal indications, timing, dosage, and safety profiles for children.
• This case highlights a potential therapeutic avenue for a critically ill pediatric population.